EMA committee adopts positive opinion on Opdivo in locally advanced or metastatic urothelial cancer April 24, 2017
Atara and Merck & Co. in clinical trial collaboration to evaluate ATA-129 with pembrolizumab April 24, 2017
EMA renders negative trend vote on XBiotech's MAA for colorectal cancer candidate antibody April 21, 2017
MedImmune begins first-in-human study of MEDI-5083 alone and with durvalumab in solid tumors April 20, 2017
RSS